Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Allergan Medical |
---|---|
Information provided by: | Allergan Medical |
ClinicalTrials.gov Identifier: | NCT00534339 |
Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.
Condition | Intervention |
---|---|
Morbid Obesity |
Device: Easyband (Telemetrically adjustable gastric banding device) |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 300 |
Study Start Date: | December 2009 |
Estimated Study Completion Date: | July 2013 |
Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Allergan Medical | 800-624-4261 | devicetrials@allergan.com |
United States, California | |
USA, California, United States | |
Canada, Quebec | |
Canada, Quebec, Canada |
Study Director: | Allergan Medical | Allergan Medical |
Responsible Party: | Allergan ( Allergan Medical ) |
Study ID Numbers: | 10042 |
Study First Received: | September 21, 2007 |
Last Updated: | December 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00534339 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Body Weight Signs and Symptoms Obesity Nutrition Disorders |
Overweight Overnutrition Obesity, Morbid |
Body Weight Signs and Symptoms Obesity Nutrition Disorders |
Overweight Overnutrition Obesity, Morbid |